Compare ADMA Biologics Inc (ADMA) vs FedEx Corporation (FDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs FedEx Corporation — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while FedEx Corporation trades at $322.99 (market cap $76.28B). The key difference: FedEx Corporation is far larger — about 34.4× ADMA Biologics Inc's market cap, and FedEx Corporation pays a 1.51% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | FDX | |
|---|---|---|
Market Cap | $2.22B | $76.28B |
Sector | Health | Industrials |
52-Week High | $20.38 | $338.75 |
52-Week Low | $7.60 | $180.51 |
Enterprise Value | $2.29B | $105.91B |
Dividend Yield | — | 1.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →
